Reagents: CDDO-Me
1 was synthesized from oleanolic acid according to a previously described method[5 (
link)] with 10 % yield (NMR
1H and
13C data).
18βH-Glycyrrhetinic acid acetate
2, obtained from a licorice extract, was used as starting material (purity∼94 %).[39 ]
General experimental procedures: Melting points were determined on a Hoover melting point apparatus and were uncorrected. The elemental composition of the products was determined from high-resolution mass spectra recorded on a DFS (Double Focusing Sector) Thermo Electron Corporation instrument.
1H and
13C NMR spectra were measured from CDCl
3 solutions on Bruker spectrometers: AM-400 (400.13
mhz for
1H, 100.61
mhz for
13C) and DRX-500 (500.13
mhz for
1H, 125.76
mhz for
13C). Chloroform was used as the internal standard (
δH 7.24 ppm,
δC 76.90 ppm). The structure of the compounds was determined by NMR from proton spin–spin coupling constants in
1H,
1H double-resonance spectra, and by analyzing
13C NMR proton-selective and off-resonance saturation spectra, 2D
13C,
1H correlated spectroscopy on CH constants (COSY,
1JC,H=135 Hz; and COLOC,
2, 3JC,H=10 Hz, correspondingly), and 1D
13C,
1H long-range
J modulation difference (LRJMD,
JC,H=10 Hz). Flash column chromatography was performed with silica gel (Merck, 60–200 mesh) and neutral alumina (Chemapol, 40–250 mesh).
Methyl 18βH-Glycyrrhetinate acetate (3):[42 ] A solution of diazomethane in ether was added dropwise at 0°C to a stirred suspension of
2 (10 g, 19.0 mmol) in methanol (200 mL) until the originally colorless mixture turned yellow. The resulting mixture was allowed to stand at room temperature overnight. The solvent was removed and the product was purified by crystallization (chloroform/methanol; yield=9.1 g, 89 %). M.p. 303–304°C;
1H NMR (CDCl
3):
δ=0.76 (dd,
3J(H
5a,H
6a)=12.5,
3J(H
5a,H
6e)=1.5 Hz; H
5a), 0.76 (s, 3 H; C28-H
3), 0.84 (s, 6 H; C23-H
3, C24-H
3), 0.97 (dm,
2J(H
16e,H
16a)=13.8 Hz; H
16e), 1.01 (ddd,
2J(H
1a,H
1e)=13.5,
3J(H
1a,H
2a)=13.5,
3J(H
1a,H
2e)=3.7 Hz; H
1a), 1.08 (s, 3 H; C26-H
3), 1.10 (s, 3 H; C29-H
3), 1.12 (s, 3 H; C25-H
3), 1.14 (dm,
2J(H
15e,H
15a)=13.8 Hz; H
15e), 1.23–1.39 (m, 4 H; H
7, H
21a, 2 H
22), 1.32 (s, 3 H; C27-H
3), 1.41 (dddd,
2J(H
6a,H
6e)=13.5,
3J(H
6a,H
7a)=13.5,
3J(H
6a,H
5a)=12.0,
3J(H
6a,H
7e)=3.2 Hz; H
6a), 1.51–1.66 (m, 3 H; H
6e, H
2e, H
7′), 1.57 (dd,
2J(H
19a,H
19e)=13.5,
3J(H
19a,H
18a)=13.5 Hz; H
19a), 1.66 (dddd,
2J(H
2a,H
2e)=13.5,
3J(H
2a,H
1a)=13.5,
3J(H
2a,H
3a)=11.7,
3J(H
2a,H
1e)=3.7 Hz; H
2a), 1.78 (ddd,
2J(H
15a,H
15e)=13.8,
3J(H
15a,H
16a)=13.8,
3J(H
15a,H
16e)=4.5 Hz; H
15a), 1.88 (ddd,
2J(H
19e,H
19a)=13.5,
3J(H
19e,H
18a)=4.2,
4J(H
19e,H
21e)=2.7 Hz; H
19e), 1.95 (dm
2J(H
21e,H
21a)=10 Hz; H
21e), 1.98 (ddd,
2J(H
16a,H
16e)=13.8,
3J(H
16a,H
15a)=13.8,
3J(H
16a,H
15e)=4.8 Hz; H
16a), 2.00 (s, 3 H; C33-H
3), 2.04 (dd,
3J(H
18a,H
19a)=13.5,
3J(H
18a,H
19e)=4.2 Hz; H
18a), 2.32 (s, 1 H; H
9a), 2.76 (ddd
2J(H
1e,H
1a)=13.5,
3J(H
1e,H
2a)=3.7,
3J(H
1e,H
2e)=3.0 Hz; H
1e), 3.64 (s, 3 H; OC31-H
3), 4.47 (dd,
3J(H
3a,H
2a)=11.7,
3J(H
3a,H
2e)=4.7 Hz; H
3a), 5.62 (s, 1 H; H
12);
13C NMR (CDCl
3):
δ=38.63 (t, C1), 23.41 (t, C2), 80.45 (d, C3), 37.88 (s, C4), 54.88 (d, C5), 17.22 (t, C6), 32.55 (t, C7), 43.03 (s, C8), 61.56 (d, C9), 36.78 (s, C10), 199.85 (s, C11), 128.34 (d, C12), 169.01 (s, C13), 45.23 (s, C14), 26.31 (t, C15), 26.26 (t, C16), 31.67 (s, C17), 48.25 (d, C18), 40.93 (t, C19), 43.87 (s, C20), 30.98 (t, C21), 37.59 (t, C22), 27.89 (q, C23), 16.52 (q, C24), 16.24 (q, C25), 18.52 (q, C26), 23.17 (q, C27), 28.36 (q, C28), 28.15 (q, C29), 176.73 (s, C30), 51.58 (q, C31), 170.77 (s, C32), 21.13 (q, C33); HRMS:
m/z calcd for C
33H
50O
5: 526.7471; found: 526.3658.
Methyl 3 β-Acetoxy-18 βH-olean-12-en-30-oate (4):[43 ] A solution of conc. hydrochloric acid (50 mL) was added dropwise at 10°C to a stirred suspension of
3 (9.1 g, 17.3 mmol) and zinc powder (18.2 g, 280 mmol) in dioxane (300 mL) over 2 h. The reaction mixture was stirred for a further 3 h at 5–10°C, concentrated in a vacuum, diluted with water (1 L), and filtered. The solid was dried and subjected to flash column chromatography (silica gel; benzene followed by chloroform) to give crude
4 (yield=6.8 g, 77 %). This material was used for the next reaction without further purification. An analytically pure sample was obtained by recrystallization from a mixture chloroform/methanol. M.p. 265–267°C;
1H NMR (CDCl
3):
δ=0.74 (s, 3 H; C28-H
3), 0.81 (dd,
3J(H
5a,H
6a)=12.0,
3J(H
5a,H
6e)=1.6 Hz; H
5a), 0.82–0.86 (m, H
16e), 0.83 (s, 3 H; C24-H
3), 0.84 (s, 3 H; C23-H
3), 0.93 (s, 6 H; C25-H
3, C26-H
3), 0.94 (dm
2J(H
15e,H
15a)=13.5 Hz; H
15e), 1.02 (m; H
1), 1.09 (s, 3 H; C29-H
3), 1.10 (s, 3 H; C27-H
3), 1.17–1.35 (m, 4 H; H
7, H
21, 2 H
22), 1.39 (m, H
6a), 1.44–1.64 (m, 7 H; H
1′, 2 H
2, H
6e, H
7′, H
9a, H
19), 1.73 (ddd,
2J(H
15a,H
15e)=13.5,
3J(H
15a,H
16a)=13.5,
3J(H
15a,H
16e) 4.6 Hz; H
15a), 1.79–1.93 (m, 5 H; 2 H
11, H
18, H
19′, H
21′), 1.92 (m; H
16a), 2.01 (s, 3 H; C33-H
3), 3.64 (s, 3 H; OC31-H
3), 4.47 (dd,
3J(H
3a,H
2a)=10.0,
3J(H
3a,H
2e)=6.0 Hz; H
3a), 5.23 (t,
2J(H
12,H
11)=3.6 Hz; H
12);
13C NMR (CDCl
3):
δ=38.13 (t, C1), 23.42 (t, C2), 80.74 (d, C3), 37.56 (s, C4), 55.13 (d, C5), 18.11 (t, C6), 32.46 (t, C7), 39.65 (s, C8), 47.42 (d, C9), 36.70 (s, C10), 23.34 (t, C11), 122.34 (d, C12), 144.23 (s, C13), 41.38 (s, C14), 25.99 (t; C15), 26.82 (t, C16), 31.79 (s, C17), 48.05 (d, C18), 42.68 (t, C19), 44.12 (s, C20), 31.15 (t, C21), 38.25 (t, C22), 27.89 (q, C23), 16.54 (q, C24), 15.41 (q, C25), 16.64 (q, C26), 25.77 (q, C27), 28.03 (q, C28), 28.38 (q, C29), 177.46 (s, C30), 51.35 (q, C31), 170.77 (s, C32), 21.13 (q, C33); HRMS:
m/z calcd for C
33H
52O
4: 512.7636; found: 512.3866.
Methyl 3β-acetoxy-12-oxo-18βH-olean-30-oate (5): A mixture of hydrogen peroxide (∼30 %, 25 mL) and acetic acid (25 mL) was added dropwise at 80°C to a stirred suspension of
4 (3.0 g, 5.7 mmol) in acetic acid (100 mL) over 1 h. The reaction mixture was stirred for a further 30 min at 80°C, cooled to room temperature, and diluted with water (500 mL). The solid was filtered, washed with water, and dried to give crude
5 (yield=6.8 g, 96 %). This material was used for the next reaction without further purification. An analytically pure sample was obtained by recrystallization from a mixture chloroform/methanol. M.p. 296–299°C;
1H NMR (CDCl
3):
δ=0.79–0.88 (m, 2 H; H
5a, H
16e), 0.82 (s, 3 H; C28-H
3), 0.83 (s, 3 H; C24-H
3), 0.84 (s, 3 H; C23-H
3), 0.86 (s, 3 H; C25-H
3), 0.90 (s, 3 H; C27-H
3), 0.92–1.01 (m, 2 H; H
1, H
15e), 1.09 (s, 3 H; C29-H
3), 1.10 (s, 3 H; C26-H
3), 1.19 (dd,
2J(H
19a,H
19e)=13.4,
3J(H
19a,H
18)=13.4 Hz; H
19a), 1.18–1.27 (m, 2 H; H
21a, H
22e), 1.31–1.48 (m, 4 H; 2 H
7, H
22a, H
6), 1.49–1.64 (m, 4 H; H
1′, 2 H
2, H
6′), 1.64 (dd
3J(H
9a,H
11a)=13.0,
3J(H
9a,H
11e)=5.1 Hz; H
9a), 1.74 (m, H
18), 1.76 (m, H
15a), 1.85 (ddd,
2J(H
16a,H
16e)=13.2,
3J(H
16a,H
15a)=13.2,
3J(H
16a,H
15e)=4.2 Hz; H
16a), 1.91 (dm,
2J(H
21e,H
21a)=13.2 Hz; H
21e), 2.00 (s, 3 H; C33-H
3), 2.12 (dd,
2J(H
11a,H
11e)=17.0,
3J(H
11a,H
9a)=13.0 Hz; H
11a), 2.23 (dd,
2J(H
11e,H
11a)=17.0,
3J(H
11e,H
9a)=5.1 Hz; H
11e), 2.54 (ddd,
2J(H
19e,H
19a)=13.4,
3J(H
19e,H
18)=3.4,
4J(H
19e,H
21e)=2.8 Hz; H
19e), 2.72 (d,
3J(H
13,H
18)=4.4 Hz; H
13), 3.68 (s, 3 H; OC31-H
3), 4.44 (dd,
3J(H
3a,H
2a)=11.4,
3J(H
3a,H
2e)=4.8 Hz; H
3a);
13C NMR (CDCl
3):
δ=37.50 (t, C1), 23.26 (t, C2), 80.28 (d, C3), 37.60 (s, C4), 55.04 (d, C5), 18.05 (t, C6), 31.63 (t, C7), 41.41 (s, C8), 49.32 (d, C9), 36.67 (s, C10), 38.28 (t, C11), 211.91 (s, C12), 50.08 (d, C13), 41.90 (s, C14), 25.84 (t, C15), 26.29 (t, C16), 32.01 (s, C17), 38.41 (d, C18), 34.05 (t, C19), 43.97 (s, C20), 31.19 (t, C21), 38.33 (t, C22), 27.75 (q, C23), 16.30 (q, C24), 15.16 (q, C25), 15.95 (q, C26), 20.78 (q, C27), 26.83 (q, C28), 28.59 (q, C29), 177.44 (s, C30), 51.36 (q, C31), 170.70 (s, C32), 21.09 (q, C33); HRMS:
m/z calcd for C
33H
52O
5: 528.7630; found: 528.3815.
Methyl 3β-acetoxy-12-oxo-18βH-olean-9(11)-en-30-oate (6): Compound
6 was synthesized according to a known method.[44 ] Briefly, a solution of bromine (0.5 mL, 9.8 mmol) in glacial acetic acid (50 mL) was added dropwise at 80°C to a stirred solution of
5 (4.0 g, 7.6 mmol) in glacial acetic acid (150 mL) over 1 h. The reaction mixture was stirred for a further 1 hour at 80°C, cooled to room temperature, diluted with water (1.5 L) and filtered. The solid was washed with water, dried, and subjected to flash column chromatography (silica gel, chloroform) to give a solid
6 (yield=3.0 g, 75 %). This material was used for the next reaction without further purification. An analytically pure sample was obtained by recrystallization from a mixture chloroform/methanol. M.p. 298°C;
1H NMR (CDCl
3):
δ=0.84 (m; H
16e), 0.85 (s, 3 H; C24-H
3), 0.86 (s, 6 H; C23-H
3, C28-H
3), 0.91 (s, 3 H; C27-H
3), 0.94 (dm,
3J(H
5a,H
6a)=10 Hz; H
5a), 1.01 (dm,
2J(H
15e,H
15a)=13.2 Hz; H
15e), 1.07 (s, 3 H; C29-H
3), 1.16 (s, 3 H; C25-H
3), 1.20 (dd,
2J(H
19a,H
19e)=13.3,
3J(H
19a,H
18)=13.3 Hz; H
19a), 1.16–1.27 (m, 2 H; H
21a, H
22e), 1.32 (s, 3 H; C26-H
3), 1.35–1.44 (m, 2 H; H
1a, H
7e), 1.46 (ddd,
2J(H
22a,H
22e)=14.0,
3J(H
22a,H
21a)=14.0,
3J(H
22a,H
21e)=4.2 Hz; H
22a), 1.55–1.73 (m, 5 H; 2 H
6, H
7a, 2 H
2), 1.77 (m; H
15a), 1.83 (m; H
16a), 1.90 (m, 2 H; H
1e, H
21e), 1.93 (dm,
3J(H
18,H
19a)=13.3; H
18), 2.00 (s, 3 H; C33-H
3), 2.16 (ddd,
2J(H
19e,H
19a)=13.3,
3J(H
19e,H
18)=3.4,
4J(H
19e,H
21e)=2.8 Hz; H
19e), 2.92 (d,
3J(H
13,H
18)=4.7 Hz; H
13), 3.69 (s, 3 H; OC31-H
3), 4.43 (dd,
3J(H
3a,H
2a)=11.7,
3J(H
3a,H
2e)=4.5 Hz; H
3a), 5.72 (s; H
11);
13C NMR (CDCl
3):
δ=35.86 (t, C1), 23.66 (t, C2), 79.49 (d, C3), 37.95 (s, C4), 50.08 (d, C5), 17.67 (t, C6), 32.66 (t, C7), 45.29 (s, C8), 177.61 (s, C9), 39.59 (s, C10), 122.89 (d, C11), 201.14 (s, C12), 47.70 (d, C13), 41.61 (s, C14), 26.03 (t, C15), 26.03 (t, C16), 31.87 (t, C17), 37.81 (d, C18), 33.69 (t, C19), 43.88 (s, C20), 31.10 (t, C21), 38.13 (t, C22), 27.77 (q, C23), 16.46 (q, C24), 23.79 (q, C25), 23.85 (q, C26), 21.84 (q, C27), 26.90 (q, C28), 28.45 (q, C29), 177.22 (s, C30), 51.32 (q, C31), 170.59 (s, C32), 21.01 (q, C33); HRMS:
m/z calcd for C
33H
50O
5: 526.7471; found: 526.3658.
Methyl 3β-hydroxy-12-oxo-18βH-olean-9(11)-en-30-oate (7): A mixture of
6 (6.2 g, 11.8 mmol) and KOH (41 g, 732 mmol) in methanol (400 mL) was heated under reflux for 1.5 h. The resulting solution was cooled to room temperature, concentrated in vacuo, and 10 % aqueous hydrochloric acid solution was added. The mixture was extracted with chloroform/ethyl acetate (1:4, 3×75 mL). The combined organic layers were washed with saturated sodium hydrogen carbonate solution (3×50 mL) and brine (3×50 mL), and dried over magnesium sulfate. The solvent was removed to give a solid
7 (yield=5.13 g, 90 %). This material was used for the next reaction without further purification. An analytically pure sample was obtained by recrystallization from a mixture chloroform/methanol. M.p. 202–203°C;
1H NMR:
δ=0.80 (s, 3 H; C24-H
3), 0.89 (s, 3 H; C28-H
3), 0.94 (s, 3 H; C27-H
3), 1.01 (s, 3 H; C23-H
3), 1.08 (s, 3 H; C29-H
3), 1.16 (s, 3 H; C25-H
3), 1.35 (s, 3 H; C26-H
3), 0.83–0.91 (m, 2 H; H
5a, H
16e), 1.04 (dm,
2J(H
15e,H
15a)=12.8 Hz; H
15e), 1.23 (dd,
2J(H
19a,H
19e)=13.2,
3J(H
19a,H
18)=13.2 Hz; H
19a), 1.18–1.25 (m; H
21a), 1.27 (dm,
2J(H
22e,H
22a)=14.0 Hz; H
22e), 1.31 (m; H
1a), 1.44 (dm,
2J(H
7e,H
7a)=9.8 Hz; H
7e), 1.49 (ddd,
2J(H
22a,H
22e)=14.0,
3J(H
22a,H
21a)=14.0,
3J(H
22a,H
21e)=4.2 Hz; H
22a), 1.55–1.76 (m, 5 H; 2 H
6, H
7a, 2 H
2), 1.80 (m, H
15a), 1.85 (m; H
16a), 1.89–2.00 (m, 3 H; H
1e, H
21e, H
18), 2.19 (ddd,
2J(H19
e,19
a)=13.2,
3J(H
19e,H
18)=3.2,
4J(H
19e,H
21e)=2.7 Hz; H
19e), 2.95 (d,
3J(H
13,H
18) 4.7 Hz; H
13), 3.18 (dd
3J(H
3a,H
2a)=11.7,
3J(H
3a,H
2e)=4.4 Hz; H
3a), 3.71 (s, 3 H; OC31-H
3), 5.76 (s, H
11);
13C NMR (CDCl
3):
δ=36.22 (t, C1), 27.38 (t, C2), 77.83 (d, C3), 39.11 (s, C4), 50.06 (d, C5), 17.87 (t, C6), 32.79 (t, C7), 45.39 (s, C8), 178.10 (s, C9), 39.81 (s, C10), 122.85 (d, C11), 201.36 (s, C12), 47.76 (d, C13), 41.70 (s, C14), 26.14 (t, C15), 26.12 (t, C16), 31.95 (s, C17), 37.88 (d, C18), 33.79 (t, C19), 43.95 (s, C20), 31.17 (t, C21), 38.21 (t, C22), 27.96 (q, C23), 15.44 (q, C24), 23.81 (q, C25), 23.87 (q, C26), 21.99 (q, C27), 26.96 (q, C28), 28.52 (q, C29), 177.33 (s, C30), 51.43 (q, C31); HRMS:
m/z calcd for C
31H
48O
4: 484.7104; found: 484.3553.
Methyl 3,12-Dioxo-18βH-olean-9(11)-en-30-oate (8): Jones reagent (5 mL), prepared from Na
2Cr
2O
7⋅2 H
2O in dilute sulfuric acid (33 %)[45 ] was added dropwise to a solution of
7 (5.13 g) in acetone (500 mL) at 0°C over 30 min till the brown color persisted. The mixture was stirred for further 2.5 h at room temperature, and ethanol (10 mL) was added. The resulting mixture was concentrated in a vacuum (∼100 mL), and water (1 L) was added. The solid was filtered and dried. The ketone
8 was purified by column chromatography (neutral alumina, chloroform) (yield=4.7 g, 94 %). This material was used for the next reaction without further purification. An analytically pure sample was obtained by recrystallization from a mixture chloroform/methanol. M.p. 189–192°C;
1H NMR (CDCl
3):
δ=0.88 (s, 3 H; C28-H
3), 0.94 (s, 3 H; C27-H
3), 1.05 (s, 3 H; C24-H
3), 1.07 (s, 3 H; C29-H
3), 1.08 (s, 3 H; C23-H
3), 1.27 (s, 3 H; C25-H
3), 1.38 (s, 3 H; C26-H
3), 0.89 (m, H
16e), 1.06 (m, H
15e), 1.21 (dd,
2J(H
19a,H
19e)=13.3,
3J(H
19a,H
18)=13.3 Hz; H
19a), 1.17–1.29 (m, 2 H; H
21a, H
22e), 1.43–1.50 (m, 2 H; H
5a, H
7), 1.48 (ddd,
2J(H
22a,H
22e)=14.0,
3J(H
22a,H
21a)=14.0,
3J(H
22a,H
21e)=4.3 Hz; H
22a), 1.60–1.72 (m, 3 H; 2 H
6, H
7′), 1.75 (m, H
1a), 1.80 (m; H
15a), 1.85 (m, H
16a), 1.92 (m, H
21e), 1.96 (ddd,
3J(H
18,H
19a)=13.3,
3J(H
18,H
13)=4.7,
3J(H
18,H
19e)=3.2 Hz; H
18), 2.16 (m, H
1e), 2.17 (ddd,
2J(H
19e,H
19a)=13.3,
3J(H
19e,H
18)=3.2,
4J(H
19e,H
21e)=2.8 Hz; H
19e), 2.44 (ddd,
2J(H
2e,H
2a)=15.8,
3J(H
2e,H
1a)=7.2,
3J(H
2e,H
1e)=3.8 Hz; H
2e), 2.60 (ddd,
2J(H
2a,H
2e)=15.8,
3J(H
2a,H
1a)=11.5,
3J(H
2a,H
1e)=7.3 Hz; H
2a), 2.98 (d,
3J(H
13,H
18)=4.7 Hz; H
13), 3.70 (s, OC31-H
3), 5.78 C(H
11);
13C NMR (CDCl
3):
δ=36.80 (t, C1), 33.97 (t, C2), 215.57 (s, C3), 47.35 (s, C4), 50.73 (d, C5), 18.97 (t, C6), 31.90 (t, C7), 45.46 (s, C8), 176.36 (s, C9), 39.23 (s, C10), 124.10 (d, C11), 200.78 (s, C12), 47.86 (d, C13), 41.78 (s, C14), 26.13 (t, C15), 26.11 (t, C16), 31.90 (s, C17), 37.82 (d, C18), 33.76 (t, C19), 43.90 (s, C20), 31.12 (t, C21), 38.14 (t, C22), 26.10 (q, C23), 21.25 (q, C24), 23.69 (q, C25), 23.75 (q, C26), 21.81 (q, C27), 26.94 (q, C28), 28.45 (q, C29), 177.19 (s, C30), 51.37 (q, C31); HRMS:
m/z calcd for C
31H
46O
4: 484.6945; found: 484.3396.
Methyl 2-hydroxymethylene-3,12-dioxo-18βH-olean-9(11)-en-30-oate (9): Ethyl formate (3.75 mL, 39.5 mmol) and sodium methylate (2.1 g, 38.9 mmol) were added to a solution of ketone
8 (4.5 g, 9.3 mmol) in dry benzene (50 mL). The mixture was stirred at room temperature for 2 h. The reaction mixture was diluted with a mixture of chloroform/diethyl ether (1:3, 100 mL), and 5 % HCl was added to achieve pH<7. The organic layer was separated, and the aqueous layer was extracted with chloroform/diethyl ether (1:3, 3×50 mL). The combined organic layers were washed with saturated sodium hydrogen carbonate solution (3×50 mL), and brine (3×50 mL), and dried over magnesium sulfate. The solvent was removed to give an amorphous solid
9 (yield=4.5 g, 95 %). This material was used for the next reaction without further purification. An analytically pure sample was obtained by flash column chromatography (silica gel; hexane/ethyl acetate (9:1) followed by hexane/ethyl acetate (3:1)).
1H NMR (CDCl
3):
δ=0.90 (s, 3 H; C28-H
3), 0.96 (s, 3 H; C27-H
3), 1.09 (s, 3 H; C29-H
3), 1.13 (s, 3 H; C24-H
3), 1.15 (s, 3 H; C25-H
3), 1.20 (s, 3 H; C23-H
3), 1.38 (s, 3 H; C26-H
3), 0.91 (m, H
16e), 1.07 (m, H
15e), 1.23 (dd,
2J(H
19a,H
19e)=13.3,
3J(H
19a,H
18)=13.3 Hz; H
19a), 1.18–1.31 (m, 3 H; H
21a, H
22e, H
5a), 1.49 (ddd,
2J(H
22a,H
22e)=14.0,
3J(H
22a,H
21a)=14.0,
3J(H
22a,H
21e)=4.1 Hz; H
22a), 1.47–1.53 (m, H
7), 1.59–1.67 (m, 3 H; 2 H
6, H
7′), 1.82 (m, H
15a), 1.86 (m, H
16a), 1.94 (dddd
2J(H
21e,H
21a)=13.3,
3J(H
21e,H
22a)=4.1,
3J(H
21e,H
22e)=3.4,
4J(H
21e,H
19e)=2.7 Hz; H
21e), 1.99 (ddd,
3J(H
18,H
19a)=13.3,
3J(H
18,H
13)=4.6,
3J(H
18,H
19e)=3.3 Hz; H
18), 2.21 (ddd,
2J(H
19e,H
19a)=13.3,
3J(H
19e,H
18)=3.3,
4J(H
19e,H
21e)=2.7 Hz; H
19e), 2.26 (d,
2J(H
1,H
1′)=14.5 Hz; H
1) and 2.58 (d,
2J(H
1′,H
1)=14.5 Hz; H
1′)—AB-system, 3.02 (d,
3J(H
13,H
18)=4.6 Hz; H
13), 3.71 (s, 3 H; OC31-H
3), 5.90 (s, H
11), 8.70 (d,
3J(H
32,OH)=2.4 Hz; H
32), 14.81 (d,
3J (OH,H
32)=2.4 Hz; OH);
13C NMR (CDCl
3):
δ=36.85 (t, C1), 104.80 (s, C2), 188.08 (s, C3), 40.32 (s, C4), 48.07 (d, C5), 18.80 (t, C6), 31.25 (t, C7), 45.55 (s, C8), 175.36 (s, C9), 38.89 (s, C10), 124.37 (d, C11), 200.73 (s, C12), 47.86 (d, C13), 41.80 (s, C14), 26.22 (t, C15), 26.14 (t, C16), 31.93 (s, C17), 37.82 (d, C18), 33.74 (t, C19), 43.93 (s, C20), 31.14 (t, C21), 38.18 (t, C22), 28.14 (q, C23), 20.65 (q, C24), 23.36 (q, C25), 23.23 (q, C26), 21.82 (q, C27), 26.96 (q, C28), 28.48 (q, C29), 177.22 (s, C30), 51.42 (q, C31), 189.65 (d, C32); HRMS:
m/z calcd for C
32H
46O
5: 510.7046; found: 510.3345.
Methyl 12-oxoisoxazolo[4,5-b]-18βH-olean-9(11)-en-30-oate (10): Hydroxylamine hydrochloride (6.0 g, 86.0 mmol) was added to a solution of
9 (4.4 g, 8.6 mmol) in ethanol (120 mL) and water (12 mL). The mixture was heated under reflux for 2 h, cooled to room temperature, concentrated in vacuo, and water (100 mL) was added. The mixture was extracted with ethyl acetate (3×70 mL). The combined organic layers were washed with water (3×50 mL), brine (3×50 mL) and dried over magnesium sulfate. The solvent was evaporated and the solid was purified by column chromatography (silica gel; hexane/ethyl acetate (3:1)) to give
10 (yield=3.2 g, 73 %).
1H NMR (CDCl
3):
δ=0.91 (s, 3 H; C28-H
3), 0.98 (s, 3 H; C27-H
3), 1.10 (s, 3 H; C29-H
3), 1.15 (s, 3 H; C25-H
3), 1.24 (s, 3 H; C24-H
3), 1.32 (s, 3 H; C23-H
3), 1.40 (s, 3 H; C26-H
3), 0.91 (m, H
16e), 1.06–1.11 (m, H
15e), 1.24 (dd,
2J(H
19a,H
19e)=13.2,
3J(H
19a,H
18)=13.2 Hz; H
19a), 1.19–1.34 (m, 2 H; H
21a, H
22e), 1.44–1.57 (m, 3 H; H
5a, H
22a, H
7), 1.64–1.79 (m, 3 H; 2 H
6, H
7′), 1.84 (m, H
15a), 1.88 (m, H
16a), 1.95 (dddd,
2J(H
21e,H
21a)=13.3,
3J(H
21e,H
22a)=4.2,
3J(H
21e,H
22e)=3.2,
4J(H
21e,H
19e)=2.7 Hz; H
21e), 2.00 (ddd
3J(H
18,H
19a)=13.2,
3J(H
18,H
13)=4.6,
3J(H
18,H
19e)=3.2 Hz; H
18), 2.21 (ddd,
2J(H
19e,H
19a)=13.2,
3J(H
19e,H
18)=3.2,
4J(H
19e,H
21e)=2.7 Hz; H
19e), 2.38 (d,
2J(H
1,H
1′)=15.0 Hz; H
1) and 2.75 (d,
2J(H
1′,H
1)=15.0 Hz; H
1′)—
AB system, 3.04 (d,
3J(H
13,H
18)=4.6 Hz; H
13), 3.73 (s, 3 H; OC31-H
3), 5.89 (s, H
11), 8.04 (s, H
32);
13C NMR (CDCl
3):
δ=33.42 (t, C1), 108.38 (s, C2), 171.94 (s, C3), 35.01 (s, C4), 49.53 (d, C5), 18.16 (t, C6), 31.24 (t, C7), 45.75 (s, C8), 175.87 (c, C9), 41.09 (s, C10), 124.65 (d, C11), 200.77 (s, C12), 47.90 (d, C13), 41.79 (s, C14), 26.27 (t, C15), 26.13 (t, C16), 31.95 (s, C17), 37.85 (d, C18), 33.79 (t, C19), 43.95 (s, C20), 31.16 (t, C21), 38.18 (t, C22), 28.65 (q, C23), 21.26 (q, C24), 24.52 (q, C25), 23.28 (q, C26), 21.87 (q, C27), 26.99 (q, C28), 28.51 (q, C29), 177.26 (s, C30), 51.47 (q, C31), 150.06 (d, C32); HRMS:
m/z calcd for C
32H
45NO
4: 507.7040; found: 507.3349.
The mixture of tautomers (11): Sodium methylate (11 g, 204 mmol) was added at 0°C to a solution of isoxazole
10 (3.0 g, 5.9 mmol) in methanol (85 mL) and diethyl ether (170 mL). The mixture was stirred at room temperature for 1 h. The resulting mixture was diluted with a mixture of chloroform/diethyl ether (1:3; 100 mL), and 5 % HCl was added to achieve pH<7. The organic layer was separated, and the aqueous layer was extracted with chloroform/diethyl ether (1:3; 3×50 mL). The combined organic layers were washed with saturated sodium hydrogen carbonate solution (3×50 mL) and brine (3×50 mL), and dried over magnesium sulfate. The solvent was removed to give a mixture of tautomers
11 (yield=3.0 g, 100 %). This material was used for the next reaction without further purification. HRMS:
m/z calcd for C
32H
45NO
4: 507.7040; found: 507.3349.
Methyl 2-cyano-3,12-dioxo-18βH-olean-9(11),1(2)-dien-30-oate (12): Mixture
11 (2.8 g, 5.5 mmol) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (1.5 g, 6.5 mmol) in dry benzene (160 mL) were heated under reflux for 4 h. Insoluble matter was removed by filtration, and the filtrate was evaporated in a vacuum to give a solid. The solid was subjected to flash column chromatography (silica gel; benzene followed by benzene/acetone (10:1)) to give crude
12. The crude product was purified by recrystallization from methanol/chloroform to give crystals
12 (yield 1.7 g, 61 %). M. p. 247–249°C;
1H NMR (CDCl
3):
δ=0.90 (s, 3 H; C28-H
3), 0.96 (s, 3 H; C27-H
3), 1.09 (s, 3 H; C29-H
3), 1.14 (s, 3 H; C24-H
3), 1.22 (s, 3 H; C23-H
3), 1.44 C (s, 3 H; C26-H
3), 1.47 (s, 3 H; C25-H
3), 0.93 (dm,
2J(H
16e,H
16a)=13.3 Hz; H
16e), 1.08 (m, H
15e), 1.20 (dd,
2J(H
19a,H
19e)=13.2,
3J(H
19a,H
18)=13.2 Hz; H
19a), 1.18–1.32 (m, 2 H; H
21a, H
22e), 1.48 (ddd,
2J(H
22a,H
22e)=14.0,
3J(H
22a,H
21a)=14.0,
3J(H
22a,H
21e)=4.2 Hz; H
22a), 1.55 (dm,
2J(H
7e,H
7a)=13.5 Hz; H
7e), 1.67–1.79 (m, 4 H; H
5a, 2 H
6, H
7a), 1.82 (m, H
15a), 1.87 (m, H
16a), 1.94 (dddd,
2J(H
21e,H
21a)=13.3,
3J(H
21a,H
22a)=4.2,
3J(H
21e,H
22e)=3.2,
4J(H
21e,H
19e)=2.8 Hz; H
21e), 2.02 (ddd,
3J(H
18,H
19a)=13.2,
3J(H
18,H
13)=4.7,
3J(H
18,
19e)=3.2 Hz; H
18), 2.17 (ddd,
2J(H
19e,H
19a)=13.2,
3J(H
19e,H
18)=3.2,
4J(H
19e,H
21e)=2.8 Hz; H
19e), 3.02 (d,
3J(H
13,H
18)=4.7 Hz; H
13), 3.72 (s, 3 H; OC31-H
3), 5.97 (s, H
11), 8.01 (s, H
1);
13C NMR (CDCl
3):
δ=165.65 (d, C1), 114.46 (s, C2), 196.42 (s, C3), 44.86 (s, C4), 47.57 (d, C5), 18.12 (t, C6), 31.58 (t, C7), 45.82 (s, C8), 168.18 (s, C9), 42.36 (s, C10), 124.17 (d, C11), 199.52 (s, C12), 48.04 (d, C13), 42.10 (s, C14), 26.03 (t, C15), 26.00 (t, C16), 31.88 (s, C17), 37.75 (d, C18), 33.61 (t, C19), 43.91 (s, C20), 31.11 (t, C21), 38.14 (t, C22), 26.88 (q, C23), 21.40 (q, C24), 26.61 (q, C25), 24.77 (q, C26), 21.81 (q, C27), 26.96 (q, C28), 28.46 (q, C29), 177.13 (s, C30), 51.48 (q, C31), 114.22 (s, C32); HRMS:
m/z calcd for C
32H
43NO
4: 505.6881; found: 505.3192.
Cell culture and glycyrrhetinic acids derivatives: Human KB-3-1 epidermoid carcinoma cell line, HeLa cervical epithelioid carcinoma cell line, MCF-7 breast adenocarcinoma cell line, SKNMC neuroblastoma cell line (Russian Cell Culture Collection, St. Petersburg), KB-8-5 multidrug resistant cancer cell line (kindly provided by Professor M. Gottesman (NIH, USA)), were cultured in DMEM supplemented with 10 % (
v/
v) heat-inactivated fetal bovine serum, penicillin (100 U mL
−1; ICN Biomedicals, Inc), streptomycin (100 μg mL
−1) and amphotericin (250 μg mL
−1). Cells were maintained in a humidified atmosphere (5 % CO
2, 37°C). The KB-8-5 cell line was incubated in the additional presence of vinblastine (300 nmol
l−1).
Glycyrrhetinic acids derivatives were dissolved in DMSO (10 mmol
l−1), and stock solution were stored at −20°C.
After treatments, both floating and adherent scraped cells were collected by centrifugation, and used for further analysis.
Cell viability analysis by MTT assay: Cancer cells, growing in log phase, were seeded in triplicate 96-well plates at a density of 5×10
3 cells per well for HeLa cells, 7×10
3 for KB-3-1, KB-8-5 and MCF-7 cells, and 30×10
3 for SKNMC cells. The plates were incubated at 37°C in humidified 5 % CO
2 atmosphere. Cells were allowed to adhere to the surface for 24 h, then treated with varying doses of the compounds for 24 h. Aliquots of [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) solution (10 μL, 5 mg mL
−1) were added to each well, and the incubation was continued for an additional 3 h. The dark blue formazan crystals (formed within healthy cells) were solubilized with DMSO, and the absorbance was measured at 570 nm in a Multiscan RC plate reader (Thermo LabSystems, Finland). The IC
50 was determined as the compound concentration required to decrease the
A570 to 50 % of the control (no compound, DMSO), and was determined by interpolation from dose-response curves.
Analysis of antioxidant effect on the cytotoxicity of compound 12: KB-3-1 cells growing in the log phase were seeded in triplicate in 96-well plates (7×10
3 cells per well). The plates were incubated at 37°C in a humidified 5 % CO
2 atmosphere. Cells were allowed to adhere to the surface for 24 h, then treated with GSH (1, 5, 15 or 45 m
m) or with ascorbic acid (1, 3 or 5 m
m), both alone and in combination with
12 (1 μ
m). Cells were incubated with the compounds for 24 h and cell viability was analyzed by the MTT assay as described above.
Morphological observation of nuclear change: KB-3-1 cells were seeded into 24-well plates (10
5 cells per well) containing glass cover slips. Cells were allowed to adhere to the surface for 24 h. Cells were treated with
12 (1 μ
m) or with DMSO (0.1 % (
v/
v)) for 6, 18 or 24 h at 37°C in a humidified 5 % CO
2 atmosphere. After incubation, cells were fixed with 4 % formaldehyde for 15 min, and then stained for 30 min with Hoechst 33258 (200 ng mL
−1). Cells were analyzed for the presence of fragmented nuclei and condensed chromatin by fluorescent microscopy.
Apoptosis detection by Annexin V staining: Log-phase KB-3-1 cells in six-well plates (5×10
5 cells per well) were treated with
12 (0.3 μ
m or 1 μ
m) or with DMSO (0.1 % (
v/
v)) for 4, 18 or 24 h. The cells were stained with Annexin V-FITC and propidium iodide by using the ApopNexin-FITC apoptosis detection kit (Chemicon Millipore) according to the manufacturer's instructions. Briefly, cells were collected by scraping, washed twice with cold PBS, and centrifuged (400
g, 5 min). Cells were resuspended in binding buffer (1 mL) at a concentration of 1×10
6 cells per mL, then a sample (200 μL) was transferred to a 5 mL culture tube, and Annexin V-FITC (3 μL) and 100×PI (2 μL) were added. Cells were incubated for 15 min at room temperature in the dark. Finally, binding buffer (300 μL) was added to each tube, and the quantity of apoptotic cells in samples was analyzed by flow cytometry (FC500, Beckman Coulter, USA). For each sample, 10 000 ungated events were acquired. Annexin V
+/PI
− cells represented early apoptotic populations. Annexin V
+/PI
+ cells represented either late apoptotic or secondary necrotic populations.
Mitochondria depolarization analysis: Mitochondria involvement in apoptosis was measured by the mitochondrial depolarization that occurs early during the onset of apoptosis. KB-3-1 cells were treated with
1 (1 μ
m),
12 (1 μ
m) or DMSO (0.1 % (
v/
v)) for 6 h, and loss of mitochondrial potential was determined by using the mitochondrial potential sensor JC-1 (Molecular Probes, Invitrogen).
Flow cytometry assay: Cells were incubated for the appropriate time with the compounds, then collected, incubated in complete media in the dark with JC-1 (5 μg mL
−1) at 37°C for 15 min, and washed with PBS. At the end of the incubation period the cells were washed twice with cold PBS, and resuspended in PBS (400 μL). J-aggregate and J-monomer fluorescence were recorded in the channesl 2 (FL2) and 1 (FL1), respectively, of an FC500 flow cytometer. Necrotic fragments were electronically gated out, on the basis of morphological characteristics on the forward light scatter versus side light scatter dot plot.
Fluorescent microscopy assay: Cells were plated into 24-well plates (10
5 cells per well) containing glass cover slips, and allowed to adhere to the surface for 24 h. Cells were incubated for the appropriate time with the compounds. After incubation the cell culture media was removed and replaced with JC-1 reagent (5 μ
m) diluted in PBS. Cells were incubated at 37°C in a 5 % CO
2 incubator for 15 min, and analyzed by fluorescence microscopy.
Cytofluorimetric analysis of DNA content: Exponentially growing KB-3-1 cells in 6-well plates (5×10
5 cells per well) were treated with
12 (0.3 μ
m, or 1 μ
m) or DMSO (0.1 % (
v/
v)) for 18 h. After incubation, the cells were collected by centrifugation (400
g, 10 min), fixed with ice-cold 70 % ethanol for at least 1 h at 4°C and treated with RNase A from bovine pancreas (1 mg mL
−1; Sigma) for 30 min at 37°C. PI (50 μg mL
−1) was then added to the solution and the DNA content was quantitated by a flow cytometry. Cells in sub-G1 phase were considered apoptotic.
Analysis of caspase activation: After treatment of KB-3-1 cells with
1 (0.3 μ
m, 1 μ
m), or
12 (0.3 μ
m, 1 μ
m), or DMSO (0.1 % (
v/
v)) for 18 h, caspase activation was assayed by using the CaspACE FITC-VAD-FMK in situ marker (Promega).
Flow cytometry assay: Cells were incubated for the appropriate time in the presence of the compounds, collected, suspended in PBS (0.5 mL), and FITC-VAD-FMK (1 μL, 5 m
m) was added. The cells were gently mixed and incubated for 20 min at RT in the dark. Cells were washed twice with PBS, and the pellets resuspended in PBS (0.5 mL). Flow cytometry was conducted within 10 min.
Fluorescent microscopy assay: Cells were seeded (10
5 cells per well) into 24-well plates containing glass cover slips, and allowed to adhere to the surface for 24 h. After incubation for the appropriate time with the compounds, the cell culture medium was removed and replaced with JC-1 reagent (5 μ
m) diluted in PBS. Cells were incubated at 37°C in a 5 % CO
2 incubator for 15 min. The cells were washed twice with PBS, and caspase activation was analyzed by fluorescence microscopy within 10 min.
Logashenko E.B., Salomatina O.V., Markov A.V., Korchagina D.V., Salakhutdinov N.F., Tolstikov G.A., Vlassov V.V, & Zenkova M.A. (2011). Synthesis and Pro-Apoptotic Activity of Novel Glycyrrhetinic Acid Derivatives. Chembiochem, 12(5), 784-794.